FEB ~ 4 2004 4,
kore &
14.0 510(k) Safety Summary
A. Name of Device
/ Trade Name: Thermage ThermaCoo! System
Common Name: Electrosurgical Unit and Accessories
Classification Name: Device, Electrosurgical Cutting and Coagulation and
Accessories (21 CFR 878.4400)
Contact Person: Pamela M. Buckman, RN, MS
Vice President of Regulatory/Clinical Affairs
B. Predicate Devices
ThermaCool TC System:
Premarket Notification
ThermaCool TC System (Model TC K021402, Cleared 11/5/02
ThermaCool TC System (Model TC K013639, Cleared 1/29/02
Thermage ThermaCool IIA System K013034, Cleared 10/4/01
Thermage ThermaCool Il System K003183, Cleared 12/8/00
Thermage ThermaCool System K000944, Cleared 7/19/00
Other ThermaCool System Accessories that are the subject of this 510(k) include:
coer GEO fam
Coupling Fluid Fluid TF-2 K030142, Cleared 2/3/03
17
Thermage ThermaCool System 5 10(k)

. Ya
ko 337M /C. Device Description
The Thermage ThermaCool System consists of the following components:
e ThermaCool System
e Handpiece Assembly (consisting of Handpiece and Treatment Tip)
e Accessories: Coolant Canister, Coupling Fluid, Return Pad and Skin
Marking Paper
e Accessory cables and tubing
e Optional footswitch component
D. Indicated Use
The Thermage ThermaCool System is indicated for use in Dermatologic and
General Surgical procedures for electrocoagulation and hemostasis. Non-invasive
treatment of periorbital wrinkles and rhytids.
E. Technical characteristics
The technological characteristics of the Thermage ThermaCool System are
substantially equivalent to those of the Thermage ThermaCool TC System,
ThermaCool IIA System, ThermaCool II System, and ThermaCool System.
FF. Summary
By virtue of design, principle of operation, materials and intended use, the
Thermage ThermaCool System is substantially equivalent to devices currently
cleared for marketing in the United States.
18
Thermage ThermaCool System 510(k)

sg
g & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
B ee
"ee
Food and Drug Administration
9200 Corporate Boulevard
FEB -~4 2004 Rockville MO 20850
Ms. Pamela M. Buckman, RN. MS
Vice President of Regulatory/Clinical Affairs
Thermage, Inc.
4058 Point Eden Way
Hayward, California 94545-3721
Re: K033942
‘lyade/Device Name: Thermage ThermaCool System and Coupling Fluid
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: December 18. 2003
Received: December 19, 2003
Dear Ms. Buckman:
We have reviewed your Section 510(k) premarkct notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or tu
devices that have been reclassified in accordance with the provisions of the Federal Pood. Druz.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PATS)
You may. therefore. market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class IT (Special Controls) or class II] (PMA). il
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that fDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including. but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the electronic
product radiation control provisions (Sections 531-542 of the Act): 2! CFR £000-1050.

Page 2 — Ms. Pamela M. Buckman, RN, MS
This letter will allow you to begin marketing your device as described in your Section 510k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification tor your device and thus. permits vour device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659, Also, please note the regulation entitled,
"Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/edrh/dsma/dsmamain. htm!)

Sincerely yours.

Ecolia M. Witten, Ph.D. M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

510(k) NUMBER (IF KNOWN): KC 2337 7A
DEVICE NAME: Thermage ThermaCool System and Coupling Fluid
INDICATIONS FOR USE:
The Thermage ThermaCool System is indicated for use in Dermatologic and General
Surgical procedures for electrocoagulation and hemostasis.
Non-invasive treatment of periorbital wrinkles and rhytids.
Prescription X OR Over-The-Counter-Use
Use
(Per 21 CFR 801,109)
Concurrence of CDRH, Office of Device Evaluation (ODE)
oto CHD
os Goneral, Restorative
osCusvavigioni Devices

